| POLYMODa | Roxanne | CoRoVa |
---|---|---|---|
Undiscounted cases | Â | Â | Â |
   Mild | 22,708 | 32,186 | 28,680 |
   Moderate | 10,360 | 14,580 | 10,430 |
   Severe | 1,658 | 2,324 | 1,806 |
   Nosocomial | 415 | 528 | 452 |
   Deaths | 1 | 1 | 1 |
   GP-visits | 12,019 | 14,580 | 10,430 |
   Inpatient (comm. acq.) | 1,658 | 2,324 | 1,860 |
Discounted savings | Â | Â | Â |
   Outpatient | €480,745 | €556,984 | €829,111 |
   Inpatient | €4,643,286 | €5,949,119 | €4,714,920 |
   Indirect | € 1,322,021 | € 2,111,857 | € 2,088,993 |
Discounted net costs b | € 9,032,932 | € 9,842,807 | € 9,518,208 |
Discounted QALYs | Â | Â | Â |
   Mortality | 25 | 27 | 26 |
   Morbidity | 131 | 166 | 142 |